Association between terbinafine and arthralgia, fever and urticaria: Symptoms or syndrome?

Pharmacoepidemiology and Drug Safety

Volumn 10, Issue 2, 2001, Pages 135-142

  Van Puijenbroek, Eugène P ^a   Egberts, Antoine C G ^b,c   Meyboom, Ronald H B ^a   Leufkens, Hubert G M ^b  

^a NETHERLANDS PHARMACOVIGILANCE CENTRE LAREB   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c GGZ Midden Brabant   (Netherlands)

Author keywords

Allergy; Arthralgia; Pharmacovigilance; Terbinafine

Indexed keywords

ANTIFUNGAL AGENT; BECLOMETASONE; BUDESONIDE; DESOGESTREL; DICLOFENAC; DOMPERIDONE; DOXYCYCLINE; ETHINYLESTRADIOL; IBUPROFEN; MICONAZOLE; NABUMETONE; PREDNISOLONE; PROMETHAZINE; TERBINAFINE; TERFENADINE;

ADULT; AGED; ARTHRALGIA; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG APPROVAL; DRUG MARKETING; DRUG SURVEILLANCE PROGRAM; FEMALE; FEVER; GASTROINTESTINAL DISEASE; GENDER; HUMAN; IMMUNE RESPONSE; MALE; NETHERLANDS; ONYCHOMYCOSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; SKIN DISEASE; STATISTICAL ANALYSIS; SYMPTOM; URTICARIA;

ADULT; AGED; ANTIFUNGAL AGENTS; ARTHRALGIA; DRUG MONITORING; FEMALE; FEVER; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; NETHERLANDS; PHARMACOEPIDEMIOLOGY; SYNDROME; URTICARIA;

EID: 0034954890     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.581     Document Type: Article

References (46)

1. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses
2. Treatment of onychomycosis with terbinafine
3. Clinical efficacy and tolerability of terbinafine (Lamisil) - A new topical and systemic fungicidal drug for treatment of dermatomycoses
4. Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: Four case reports and a review of drug-induced psoriasis
5. Safety of oral terbinafine: Results of a postmarketing surveillance study in 25,884 patients
6. Oral terbinafine: A new antifungal agent
7. Toxic epidermal necrolysis induced by terbinafine in a patient on long-term anti-epileptics
8. Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine
9. Terbinafine and erythema multiforme
10. Oral terbinafine and erythema multiforme
11. Stevens-Johnson syndrome after terbinafine therapy
12. Loss of taste and terbinafine
13. Loss of taste and terbinafine
14. Nieuwe regels voor het melden van bijwerkingen in Nederland na 1995
15. Comparing safety of drugs
16. Underreporting of suspected adverse drug reactions to newly marketed ('black triangle') drugs in general practice: Observational study
17. Is reporting rate a good predictor of risks associated with drugs?
18. The under-reporting of adverse drug reactions seen in general practice
19. Serum sickness-like reactions to cefaclor
20. Non-puerperal lactation associated with antidepressant drug use
21. Clinical pharmacokinetics of terbinafine (Lamisil)
22. Terbinafine: An update
23. Postmarketing surveillance of oral terbinafine in the UK: Report of a large cohort study
24. Serum sickness-like reaction associated with oral terbinafine therapy
25. Drug-induced arthritis and arthralgia
26. Doxycycline-induced parotitis
27. Is there an allergic synovitis?
28. Hypersensitivity reaction to terbinafine
29. Hypersensitivity syndrome reaction to oral terbinafine
30. Acute generalized exanthematous pustulosis induced by terbinafine
31. Terbinafine-induced acute generalized exanthematous pustulosis
32. Severe pustular psoriasis provoked by oral terbinafine
33. Terbinafine-induced lupus erythematosus
34. Terbinafine-induced subacute cutaneous lupus erythematosus
35. Exacerbation of systemic lupus erythematosus induced by terbinafine
36. Terbinafine and fixed drug eruption
37. Severe erythema anulare centrifugum-like psoriatic drug eruption induced by terbinafine
38. Erythema multiforme (Stevens-Johnson syndrome) - Chart review of 123 hospitalized patients
39. Stevens-Johnson syndrome followed by persistent recurrent severe arthralgia
40. Serum sickness-like reaction to itraconazole
41. Signaling possible drug-drug interactions in a spontaneous reporting system: Delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole
42. Detecting drug-drug interactions using a database for spontaneous reports of adverse drug reactions: An example with diuretics and non-steroidal anti-inflammatory drugs